During the BCD disease modeling process, we observed that the individual BCD cellular phenotype (ROS, 4-HNE level, and cell death rate) varied in BCD iRPE cells from patients of different mutations in their CYP4V2 gene. The gene discussed is CYP4V2; the disease is Bietti crystalline dystrophy.